Laurus Labs Limited LAURUSLABS.BO
LAURUSLABS.BO
Laurus Labs Limited GLENMARK.NS
Glenmark Pharmaceuticals Limited GLENMARK.BO
Glenmark Pharmaceuticals Limited GLAXO.BO
GlaxoSmithKline Pharmaceuticals Limited GLAXO.NS
GlaxoSmithKline Pharmaceuticals Limited BIOCON.BO
Biocon Limited BIOCON.NS
Biocon Limited COHANCE.NS
Cohance Lifesciences Limited COHANCE.BO
Cohance Lifesciences Limited IPCALAB.BO
Ipca Laboratories Limited
Laurus Labs Limited GLENMARK.NS
Glenmark Pharmaceuticals Limited GLENMARK.BO
Glenmark Pharmaceuticals Limited GLAXO.BO
GlaxoSmithKline Pharmaceuticals Limited GLAXO.NS
GlaxoSmithKline Pharmaceuticals Limited BIOCON.BO
Biocon Limited BIOCON.NS
Biocon Limited COHANCE.NS
Cohance Lifesciences Limited COHANCE.BO
Cohance Lifesciences Limited IPCALAB.BO
Ipca Laboratories Limited
Performance
| Periode | LAURUSLABS.BO | GLENMARK.NS | GLENMARK.BO | GLAXO.BO | GLAXO.NS | BIOCON.BO | BIOCON.NS | COHANCE.NS | COHANCE.BO | IPCALAB.BO |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 43.80 % | 35.36 % | 35.34 % | -2.49 % | -2.48 % | 9.72 % | 9.76 % | -26.93 % | -27.20 % | -10.73 % |
| YTD | 49.70 % | 14.76 % | 14.80 % | 22.89 % | 23.01 % | -1.25 % | -1.22 % | -21.75 % | -21.82 % | -25.10 % |
| 1Y | 98.09 % | 7.92 % | 8.02 % | 3.68 % | 3.86 % | 7.98 % | 7.97 % | -31.20 % | -31.12 % | -21.24 % |
| 3Y | 75.02 % | 365.41 % | 365.42 % | 102.28 % | 101.42 % | 34.64 % | 34.65 % | 113.90 % | 113.91 % | 39.68 % |
| 5Y | 173.33 % | 284.00 % | 284.05 % | 77.48 % | 78.51 % | -17.28 % | -17.17 % | 165.02 % | 165.12 % | 22.72 % |
| 10Y | 858.06 % | 79.58 % | 80.09 % | 66.44 % | 66.40 % | 378.20 % | 377.96 % | 421.23 % | 423.07 % | 237.18 % |
| From the beginning | 858.06 % | 6 731.86 % | 8 855.29 % | 595.78 % | 792.91 % | 802.38 % | 803.07 % | 421.23 % | 423.07 % | 892.74 % |